Editas Medicine (EDIT) Earnings Date, Estimates & Call Transcripts $1.65 +0.10 (+6.45%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$1.66 +0.02 (+0.91%) As of 05/27/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Earnings Summary Editas Medicine issued Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.43, which topped the consensus estimate of -$0.51 by $0.08. Quarterly revenue was reported to be $4.66 million, above analysts' expectations of $0.79 million. With a trailing EPS of -$3.04, Editas Medicine's earnings are expected to grow next year, from ($2.71) to ($1.66) per share. Upcoming Q2 Earnings DateAug. 6Before Market OpensEstimatedConsensus EPS (May. 12) -$0.51 Actual EPS (May. 12) -$0.43 Beat By $0.08 Actual Revenue (May. 12) $4.66MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)EDIT Upcoming EarningsEditas Medicine's next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Editas Medicine Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Editas Medicine and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEDIT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EDIT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Editas Medicine Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.63-$0.46-$0.55Q2 20253-$0.66-$0.33-$0.44Q3 20253-$0.65-$0.14-$0.41Q4 20253-$0.68-$0.14-$0.34 FY 2025 12 -$2.62 -$1.07 -$1.73 Q1 20262-$0.63-$0.45-$0.54Q2 20262-$0.62-$0.39-$0.51Q3 20262-$0.61-$0.48-$0.55Q4 20262-$0.60-$0.18-$0.39 Editas Medicine Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/12/2025Q1 2025-$0.51-$0.43+$0.08-$0.92$0.79M$4.66M3/5/2025Q4 2024-$0.39-$0.55 -$0.16-$0.55$37.17M$30.60M11/4/2024Q3 2024-$0.75-$0.75--$0.75$3.93M$0.06M8/7/2024Q2 2024-$0.70-$0.82 -$0.12-$0.82$4.78M$0.51M5/8/2024Q1 2024-$0.63-$0.76 -$0.13-$0.76$11.14M$1.10M2/28/2024Q4 2023-$0.52-$0.23+$0.29-$0.23$4.84M$60.00M11/3/2023Q3 2023-$0.64-$0.55+$0.09-$0.55$3.70M$5.34M8/2/2023Q2 2023-$0.76-$0.56+$0.20-$0.56$4.17M$2.89M Editas Medicine Earnings - Frequently Asked Questions When is Editas Medicine's earnings date? Editas Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on EDIT's earnings history. Did Editas Medicine beat their earnings estimates last quarter? In the previous quarter, Editas Medicine (NASDAQ:EDIT) reported ($0.43) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.08. Learn more on analysts' earnings estimate vs. EDIT's actual earnings. How much revenue does Editas Medicine generate each year? Editas Medicine (NASDAQ:EDIT) has a recorded annual revenue of $35.84 million. How much profit does Editas Medicine generate each year? Editas Medicine (NASDAQ:EDIT) has a recorded net income of -$153.22 million. EDIT has generated -$3.04 earnings per share over the last four quarters. What is Editas Medicine's EPS forecast for next year? Editas Medicine's earnings are expected to grow from ($2.71) per share to ($1.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cogent Biosciences Earnings Results Xencor Earnings Results Mind Medicine (MindMed) Earnings Results Valneva Earnings Results Eton Pharmaceuticals Earnings Results Bicara Therapeutics Earnings Results Upstream Bio Earnings Results Stoke Therapeutics Earnings Results Maze Therapeutics Earnings Results Relay Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBooz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong Earnings This page (NASDAQ:EDIT) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EDIT Stock Free EDIT Stock Alerts